PlainRecalls
FDA Drug Moderate Class II Terminated

Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704

Reported: February 5, 2020 Initiated: February 14, 2019 #D-0821-2020

Product Description

Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704

Reason for Recall

Presence of Particulate Matter: Particulates observed in vials release for dispensing.

Details

Units Affected
N/A
Distribution
Prescriptions filled for patients in the following states: AK, AZ, CA, CO, DC, FL, IN, MA, MT, NC, NJ, NY, OR, SC, TX, UT, VA, WA, and WI.
Location
Santa Ana, CA

Frequently Asked Questions

What product was recalled?
Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704. Recalled by McGuff Compounding Pharmacy Services, Inc.. Units affected: N/A.
Why was this product recalled?
Presence of Particulate Matter: Particulates observed in vials release for dispensing.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 5, 2020. Severity: Moderate. Recall number: D-0821-2020.